专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

DK2257309T3 RGD-(BAKTERIE)CHLOROPHYL-KONJUGATER TIL ANVENDELSE VED DIAGNOSE AF TUMORER, DER OMFATTER NEKROTISKE DOMÆNER 未知
公开(公告)号：DK2257309T3
公开(公告)日：2020-01-20
申请号：DK09714191
申请日：2009-03-01
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： SCHERZ AVIGDOR , GOLDSHAID LIAT , SALOMON YORAM
IPC分类号： A61K41/00 , A61K49/00 , A61K49/08 , A61K49/14 , A61K51/04 , A61K51/08 , A61P35/00 , C07D257/04

2. 发明专利

BR112016002721A2 peptídeos capazes de reativar p53 mutantes 未知
公开(公告)号：BR112016002721A2
公开(公告)日：2018-07-10
申请号：BR112016002721
申请日：2014-08-07
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： MOSHE OREN , PERRY TAL , VARDA ROTTER
IPC分类号： A61K38/04 , A61P35/00 , C07K7/00
摘要： peptídeos capazes de reativar p53 mutantes, fornece peptídeos que podem reativar as p53 mutantes específica e eficazmente, bem como métodos que permitem a identificação, seleção e isolamento de tais peptídeos de forma precisa, econômica e rápida; em particular, são fornecidos peptídeos de reativação da p53 mutante que pode restaurar a dobragem da p53 tipo selvagem e, consequentemente, a atividade supressora do tumor para a proteína p53 mutante; tais peptídeos são úteis para tratar várias condições e doenças nas quais a p53 é mutada.

3. 发明专利

NO2018012I1 Padeliporfin 未知
公开(公告)号：NO2018012I1
公开(公告)日：2018-04-10
申请号：NO2018012
申请日：2018-04-10
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
IPC分类号： C07F17/02 , A61K31/40 , A61K31/7135

4. 发明专利

NO338436B1 Antistoffer mot NIK og fremstilling og anvedelse derav 未知
公开(公告)号：NO338436B1
公开(公告)日：2016-08-15
申请号：NO20062018
申请日：2006-05-05
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： WALLACH DAVID , RAMAKRISHNAN PARAMESWARAN
IPC分类号： C07K16/40 , A61K39/395 , A61P37/00 , C07K16/44 , C12N9/12 , G01N33/573

5. 发明专利

NO2018012I2 Padeliporfin 未知
公开(公告)号：NO2018012I2
公开(公告)日：2018-04-10
申请号：NO2018012
申请日：2018-04-10
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
IPC分类号： C07F17/02 , A61K31/40 , A61K31/7135

6. 发明专利

NO20161485A1 Kationiske bakterieklorofyllderivater og anvendelser derav 未知
公开(公告)号：NO20161485A1
公开(公告)日：2007-03-06
申请号：NO20161485
申请日：2016-09-19
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： COHEN AVRAHAM , SCHERZ AVIGDOR , SALOMON YORAM , BRANDIS ALEXANDER , EREN DORON
IPC分类号： C07D487/22 , A61K31/409 , A61K31/555 , A61K41/00

7. 发明专利

AU2013245471B2 Solar cells arrangement 未知
公开(公告)号：AU2013245471B2
公开(公告)日：2014-11-20
申请号：AU2013245471
申请日：2013-10-16
申请人： UNIV BAR ILAN , UNIV CALIFORNIA , YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： ZABAN ARIE , CAHEN DAVID , LUBOMIRSKY IGOR , STAFSUDD OSCAR M
IPC分类号： H01L31/00 , H01L25/00 , H01L31/042
摘要： A solar energy conversion system comprising: a substantially flat waveguide arrangement having a longitudinal core axis and having at least one light input and being configured to provide radiation propagation along the longitudinal core axis by 5 effect of total internal reflection, the waveguide arrangement comprising: a core unit for passing input solar radiation, received from the light input, along the longitudinal core axis of said core unit; and a cladding material arrangement interfacing with the core unit along said longitudinal core axis of the core unit, said cladding material arrangement being configured as an array of spaced-apart solar cells having different band gaps and 10 arranged in a descending order of their optical absorption energy threshold along the longitudinal core axis of said core unit to thereby successively interact with the radiation passing through said core unit along the longitudinal core axis, the solar cells having different optical absorption ranges, such that an interface between the core unit and the cladding material arrangement spectrally splits photons of the input solar 15 radiation while propagating through the core unit along the longitudinal core axis by causing each of the solar cells to absorb photons of different wavelengths, while reflecting photons of other wavelengths to allow their interaction with successive solar cells, resulting in that the input solar radiation is successively absorbed by said array of solar cells and thereby converted into electricity. 4744004_1 (GHMatters) P79567.AU.1 14/10/2013 ho | Waveguide Figure 1 Current collector 100 Photoactive Material 20 ] ho Wavegu de Figure 2

8. 发明专利

AU2007266557B2 Solar cells arrangement 未知
公开(公告)号：AU2007266557B2
公开(公告)日：2013-08-01
申请号：AU2007266557
申请日：2007-05-30
申请人： BAR LLAN UNIV , UNIV CALIFORNIA , YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： LUBOMIRSKY IGOR , ZABAN ARIE , STAFSUDD OSCAR M , CAHEN DAVID
IPC分类号： H01L31/00 , H01L25/00 , H01L31/042 , H02N6/00
摘要： A solar energy conversion system is presented. The system comprises at least one waveguide arrangement having at least one light input respectively. The waveguide arrangement comprises a core unit for passing input solar radiation therethrough and a cladding material arrangement interfacing with the core therealong. The cladding material arrangement is configured as an array of spaced-apart solar cells arranged along the core unit and having different optical absorption ranges, such that an interface between the waveguide core and the cladding arrangement spectrally splits the photons of the input solar radiation by causing the photons of different wavelengths, while passing through the core unit, to be successively absorbed and thereby converted into electricity by the successive solar cells of said array.

9. 发明专利

ES285087A1 PROCEDIMIENTO DE PREPARACIÓN DE UNA EMULSIÓN PARA REVESTIMIENTO Y PRESERVACIÓN DE FRUTAS Y VERDURAS 未知
公开(公告)号：ES285087A1
公开(公告)日：1963-07-01
申请号：ES285087
申请日：1963-02-12
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
IPC分类号： A23B7/16

10. 发明专利

ES2800328T3 Métodos para diagnosticar y tratar la leucemia linfocítica crónica de linfocitos B en base a la detección e inhibición de CD84 未知
公开(公告)号：ES2800328T3
公开(公告)日：2020-12-29
申请号：ES09740767
申请日：2009-09-23
申请人： YEDA RES AND DEVELOPMENT COMPANY LTD
发明人： SHACHAR IDIT , BINSKY INBAL , SOBOTTA MIRKO
IPC分类号： A61K38/17 , A61P35/02 , C07K14/705 , C07K16/28 , G01N33/574
摘要： Un método para diagnosticar B-CLL en un sujeto que lo necesita, el método comprende determinar en una muestra biológica del sujeto un nivel de isoforma C de CD84 (SEQ ID NO: 30), en donde un aumento en dicho nivel de dicha isoforma C de CD84 (SEQ ID NO: 30) por encima de un límite predeterminado con respecto a un nivel de dicho CD84 en una muestra biológica de un individuo sano es indicativo de la B-CLL.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式